
Annals of the Rheumatic Diseases
@eular_ARD
Followers
13K
Following
465
Media
2K
Statuses
6K
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology). High quality, peer reviewed research.
Joined April 2010
EULAR highlights🔵. ➡️long-term follow up data from the ARIAA study: 6months treatment intervention w Abatacept delays progression to RA for up to 4 years in ACPA+ patients w artralgia! . #EULA25.@BurjaBlaz
0
3
19
👋🏼We say goodbye to the #EULAR2025 Congress with the Highlights session, summarising all the amazing work of this edition. ⏭️ Looking forward to seeing you in London for the #EULAR2026. @RafaPrieto4
0
2
16
Great session yesterday on #DISH with a talk from @Nellziade. Even Ramses might have had it! It was very insightful also to learn about the role of comirbidities, especially #diabetes! #EULAR2025 . Posted by @msokolova_rheum
0
6
14
💉Digital ulcers in SSc. ➡️selexipag (prostacyclin receptor agonist) showed superior results in treating DU in SSc as compared to iloprost.➡️off-label use in retrospective multicentre italian study.➡️further trials needed to confirm promising results. #EULAR2025.@BurjaBlaz
0
5
20
A rarely discussed topic of #rheumatoid vasculitis - a great talk from Dr. Makol from the @MayoClinic at #EULAR2025.⭐️still very high mortality!.⭐️suspect in smn with constitutional symptoms, low complement (C3!) and ⬆️APR.⭐️RTX emerging as a treatment option.By @msokolova_rheum
1
25
76
❓How to improve adherence during the transition from paediatric to adult care?.🔝A great session including in the same session the voice of patients, HPRs and rheumatologists, supported by @FerEstevezLopez and Loreto Carmona as chairs. #EULAR2025.@RafaPrieto4
0
2
6
#EULAR2025 WIN in large vessel vasculitis. ⚠️up to 30% #PMR patients have subclinical #GCA which is associated with:.⚠️older age.⬆️ morning stiffness.⬆️hip involvement.If you start with ⬇️ than 20 mg pred in subclin. GCA-> 100% relapse risk!.Posted by @msokolova_rheum
0
10
26
Excellent talk from Dr. Jessica Manson at #EULAR2025 on the treatment of macrophage activation syndrome and why we should call it #HLH (like everyone else) .⚠️escalate early.⚠️beware of tachycardia .⚠️collaboration is key. Posted by @msokolova_rheum
0
9
13
💡How to manage Fibromyalgia? .Some take-home messages learnt during the #EULAR2025. 📖 Advocacy.⚠️ Overcoming the fear.📲 Using the power of digital health.🏃♀️Physical exercise. Posted by @RafaPrieto4
0
2
6
⚡️New insights into post-translational modifications from #EULAR2025! .⭐️#NET formation is involved in #carbamylation. Carbamylated histone H3 activates TLR4, possibly promoting osteoclastogenesis providing potential mechanism for bone erosions.OP0149.Posted by @msokolova_rheum
0
5
13
#EULAR2025 Real world data from Brazil on the combination of #MTX and #Leflunomide. 🚫NOT more liver fibrosis.🚫NOT more toxicity.Even less hospitalizations .Slightly higher ALT levels. Would you use it? 🤔 .OP0195. Posted by @msokolova_rheum
6
25
52
🧠 HPR Move Together: Moving Science into Practice.📍Walkway Hall 6 & 7 – Upper Floor. 🗓️ June 12 | 12:15–13:15.🗓️ June 13 | 12:15–13:15.🗓️ June 14 | 10:30–11:30. Let’s move science into action!.#EULAR2025 .@RafaPrieto4
0
2
1
Yesterday, we could learn the added value of including stakeholders when developing non-pharmacological interventions for people with rheumatic and muskuloskeletal diseases #EULAR2025
0
1
2
🫁screening of progressive SSc-ILD?. ➡️worsening on HRCT detects the most progressors.➡️HRCT scanning is the strongest predictor for reduced mortality.➡️yearly HRCT recommended, esp in high risk patients. #EULAR2025 .@BurjaBlaz
0
9
15
📍Foot OA affects 1 in 6 adults >50 and is often disabling. 🩺 Clinical ID is easier for 1st MTP than midfoot OA. 💉 Hyaluronan no better than saline. 👟 Prefab orthoses = rocker soles (but better adherence). Take-home messages from Hylton Menz at #EULAR2025
0
7
14
Starting the first day of the EULAR 2025 Congress learning some traditions of Barcelona's culture and its transfer to the multidisciplinary healthcare teams in Rheumatology #EULAR2025
0
2
7
Interested in #osteoarthritis? Check out our recent publication on #deeplearning & #multiomics. ➡️3 clusters based on plasma, synovial fluid and urine analyses.➡️different pathways predominated in each cluster.➡️improved clinical response performance.
0
2
5
New evidence on the role of genetic factors on #lupus development. ➡️polygenic risk scores (non-HLA) were higher in preclinical autoimmunity, and linked to ANA development.➡️pathways involved ROS, antigenic receptors and cytokines. 🔗
0
2
5
What is new on #lupus treatment?. Check out our latest publication: .➡️LLDAS and DORIS endpoints associated with improved outcomes, but infrequent with standard therapy.➡️#anifrolumab demonstrated increased rates of LLDAS & DORIS attainment up to 4 yrs. 🔗
0
2
11